Connect your AI

Axogen AXGN Change in Other Liabilities

Change in Other Liabilities at other companies

IAR

Integra LifeSciencesIART

$369K-73.4%

Other financials

Income statement

Revenue$61.5M+26.6%

Gross profit$46.2M+32.2%

Operating income-$2.8M-70.5%

Net income-$19.6M-411%

EPS (diluted)-$0.38-375%

Balance sheet

Cash & equivalents$84.7M+251%

Total debt$20.6M-69.8%

Total equity$244.8M+132%

Total assets$289.5M+47.6%

Cash flow

Operating cash flow$1.6M+112%

CapEx$2.8M+989%

Free cash flow-$1.2M+90.9%

Valuation

Market cap$2.26B+110%

Enterprise value$2.2B+91.4%

P/S9.5×+4.0×

Profitability

Gross margin75%+0.8pp

Operating margin-3.8%—

Net margin-13.2%-22.8pp

FCF margin-12.9%-3.8pp

Returns & leverage

Return on equity-18%-70.5pp

Debt / equity0.1×-0.6×

Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Axogen's change in other liabilities?: Axogen (AXGN) reported change in other liabilities of -$1K in Q1 2026.
How has Axogen's change in other liabilities changed year-over-year?: Axogen's change in other liabilities decreased by 101.6% year-over-year, from $63K to -$1K.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.